Remote Patient Monitoring Market: Growth, Size, Share, and Trends

Report Code HIT 7776
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030

Overview

The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$27.72 billion in 2024 and an impressive US$56.94 billion by 2030. The key drivers behind this growth include increasing chronic diseases, home healthcare preferences, advances in wearable technology, and the digital transformation of healthcare. Government programs, such as the FCC's COVID-19 Telehealth Program and Rural Health Care Program, are bridging gaps in broadband access in underserved and rural areas. It is making it easier for healthcare providers to offer remote care. The pandemic did push telehealth forward, but infrastructure, digital literacy, and reimbursement issues are among the many hurdles that have to be overcome for widespread adoption.

Remote Patient Monitoring (RPM) Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Remote Patient Monitoring (RPM) Market

Asia Pacific

High growth in the Asia Pacific market is attributed to the increasing geriatric population and chronic illness, improving healthcare infrastructure, rapid economic growth, and the rising standards of living.

Rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, and increasing investments in telehealth and RPM are the major factors driving the market growth.

The role and impact of AI in remote patient monitoring and the high utility of RPM in combating infectious diseases & epidemics are factors expected to offer significant growth opportunities for players operating in this market

The European remote patient monitoring market is expected to be worth USD 11.03 billion by 2030, growing at CAGR of 10.5% during the forecast period.

Data accessibility issues are expected to pose a challenge to the growth of this market

Global Remote Patient Monitoring (RPM) Market Dynamics

DRIVER: Transforming patient care through digital innovation

Remote patient monitoring is transforming healthcare delivery by using digital technologies to track and relay patient data to healthcare providers, significantly enhancing disease management and patient outcomes. This is especially valuable for individuals with chronic conditions and limited access to care. Widespread adoption of RPM is supported by Medicare, most state Medicaid programs, and private health insurers. RPM usage among Medicare beneficiaries increased more than sixfold from 2018 to 2021, with 594 monthly claims per 100,000 enrolees in 2021. As of March 2023, 34 state Medicaid programs covered RPM, though some impose restrictions. The rise of AI-powered diagnostic tools, including 103 devices for conditions such as sleep apnea, atrial fibrillation, and epilepsy, is accelerating RPM’s growth, with 75 FDA-approved AI/ML-enabled tools now available in the US.

The rapid advancement of mHealth software is fueling this market, combining wearables, sensors, and telehealth to collect real-time health data. In the US, billing for remote physiological monitoring jumped five-fold over three years, while new codes for remote therapeutic monitoring almost quadrupled in 2023. Digital health solutions focused on obesity, mental health, and musculoskeletal care are also gaining ground, with leading companies such as Accuhealth, Biofourmis, Teladoc Health, and Omron Healthcare driving innovation. As consumers demand more continuous care, these advancements, along with new reimbursement pathways, are making remote monitoring a critical component of modern healthcare systems.

RESTRAINT: High investments and lack of IT expertise

Healthcare providers struggle to use remote patient monitoring systems because they need better IT infrastructure for technology systems and data storage. A full RPM implementation demands large money expenditures to build data handling systems and maintain electronic platforms. Organizations often spend more money on running their remote monitoring systems than they do on their software purchases. Approximately one-third of ownership costs passes through support updates. When healthcare organizations don't employ experts in information technology, they need to send their staff for training at an extra expense to use Remote Patient Monitoring solutions. Small healthcare providers and organizations struggling with limited funds find it hard to adopt RPM technology because they must invest heavily in IT systems and staff training. Moving to cloud systems demands IT architecture modifications mainly in hospitals that depend on intricate network connections between labs and physicians. It becomes difficult to expand cloud-based Care Management services in large healthcare networks because they lack proper IT infrastructure connections.

 

OPPORTUNITY: Growing shift toward outpatient care environments

As the healthcare industry continues its shift toward outpatient care, Remote Patient Monitoring solutions have a huge opportunity to step forward and be the key to improving patient outcomes. The cost of outpatient procedures runs anywhere from 30-60% less than inpatient treatments, for example, making it popular due to affordability and convenience. With more than 6,300 Medicare-certified ambulatory surgery centers (ASCs) in the US as of 2024 and a 29% increase in Medicare payments for ASC procedures between 2014 and 2020, the demand for outpatient services is only rising. The trend goes hand in hand with the adoption of RPM and clinical informatics within healthcare systems, positioning them better to offer improved monitoring and care coordination-a source of improved patient experiences.

Government incentives are also encouraging this change. In 2021, public health informatics received a 80 million US dollar investment in the US, accelerating the rate at which RPM technology is embraced into outpatient care delivery. Other adjustments also made regarding the Medicare reimbursements, which even increased to a 3.8% in its ASC procedure and promotes more efficient use of innovation monitoring solution that will provide much better proactive patient care while achieving timely intervention leading to lesser cases of hospital readmission. As RPM becomes a critical part of outpatient care, it presents a valuable opportunity for growth, offering more accessible, patient-centered healthcare for the future.

CHALLENGES: Incorporation of social determinants of health (SDOH) factors into RPM Programs

Remote Patient Monitoring programs have the potential to significantly improve health outcomes, particularly for people managing chronic conditions such as diabetes, hypertension, and heart disease. However, these programs face challenges that prevent them from reaching their full potential, especially for underserved populations. Social factors such as language barriers, limited internet access, low digital health literacy, and geographic location create major obstacles. For instance, a study at NYU Langone Health found that 28.3% of those not using RPM for blood pressure monitoring were Spanish speakers. In addition, over 8.3 million US homes still lack broadband, and rural areas, particularly those with lower-income households, face even greater difficulty accessing RPM technologies. Rural hospitals near these communities are 33.5% less likely to adopt RPM for chronic care management.

The impact of these barriers is felt most acutely by racial and ethnic minorities. Hispanic and Black patients often fail to fully engage with RPM programs, which exacerbates health disparities. A 2021 study revealed that Hispanic patients were less likely to transmit data in diabetes RPM programs, and a 2023 study identified technical challenges and mistrust of healthcare systems among Black patients as major hurdles. These differences in access and engagement make it difficult for RPM to reach all who could benefit. Addressing these obstacles is critical to make sure that RPM can be used to help improve health outcomes for all, regardless of race, location, or socioeconomic status.

Global Remote Patient Monitoring (RPM) Market Ecosystem Analysis

The ecosystem of remote patient monitoring comprises telecommunications companies, i.e., network, connectivity, and hardware providers; CT tools and electronics manufacturers, i.e., the infrastructure service providers; and service & medical device providers. Healthcare providers (hospitals, health systems, physicians, ACSs, and clinics), Payers, patients/customers, health retailers, senior living/post-acute/hospice centers, start-ups, and governments and regulatory bodies are also stakeholders of this market.

Remote Patient Monitoring (RPM) Market Ecosystem
 

The hospital segment held the largest share of the healthcare providers end user market in 2023

Based on healthcare providers end-user segment, the remote patient monitoring market is segmented into hospitals; ambulatory surgical centers, ambulatory care centers, and other outpatient settings; long-term care, & assisted living facilities; home healthcare, and other healthcare providers. In 2023, the hospitals segment is accounted to hold the largest share of the remote patient monitoring market. Some of the key growth factors driving the segment are rising rates of chronic conditions such as diabetes, heart disease, and obesity, necessitating ongoing medical care and management, legislative reforms such as the Affordable Care Act, expanded access to healthcare, increasing the number of insured patients. Hospitals generate millions of data from monitoring devices. This places a huge demand for adequate data management, storage, and analysis, thus propelling the remote patient monitoring market. For instance, PainChek (Australia) partnered with InterSystems Corporation (US) in November 2022 to enhance its mobile-based pain assessment application. They integrated the app into electronic medical record systems, as that would make it of use to hospitals and eventually to new markets.

The synchronous segment is expected to see the fastest growth in transmission type of the remote patient monitoring market in 2023

The remote patient monitoring market is divided into two segments based on transmission type: synchronous and asynchronous. The synchronous segment is expected to see the fastest growth in the coming years, mainly because more patients and healthcare providers are seeking real-time monitoring and quick medical intervention. This is because advancement in telemedicine as well as in wearable devices is also driving the asynchronous remote patient monitoring. This trend is fuelled by improving patient outcomes, reduced hospital readmissions, and decreasing healthcare costs. As chronic diseases become more common and the global population ages, the need for continuous, real-time monitoring is increasing to make sure patients get timely care. The integration of AI and ML into healthcare tools is expected to make synchronous remote monitoring even more effective and efficient.

Asia Pacific is registered the highest growth during the forecast period with significant CAGR in 2023.

The remote patient monitoring market (RPM) is segmented into five major regions: North America, Asia Pacific, Europe, Middle East & Africa, and Latin America. Asia Pacific is expected to register highest growth during the forecast period. These factors include high adoption of digital health technologies, increasing healthcare expenditure, a large population, and growing age, and continuous improvements in healthcare infrastructure in this region. The researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have recently discovered an important innovation: they have designed a wearable device capable of detecting stress based on how a body reacts naturally to pain. The flexible, silver-wired device is set up in a way that feels strain and can change its electric response with time, similar to how a human body reacts repeatedly to discomfort. It could provide real-time detection and tracking of stress or discomfort, thus giving doctors a lot of data to assess a patient's condition from a distance, thereby being more proactive and personalized in care. Such innovations are likely to transform the RPM market into how we manage health, improve outcomes, and make healthcare more responsive to individual needs.

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION
Remote Patient Monitoring (RPM) Market Region

Recent Developments of Remote Patient Monitoring (RPM) Market

  • In January 2025, Medtronic (Ireland) announced the FDA approval and launch of the MyCareLink Smart Monitor, the world’s first app-based remote monitoring system for pacemaker patients.
  • In September 2024, GE HealthCare (US) launched the Venue Sprint, a portable ultrasound system offering advanced AI-driven capabilities, wireless probe integration, and enhanced workflow features.
  • In July 2024, Koninklijke Philips N.V. (Netherlands) and Bon Secours Mercy Health (US) announced a 10-year partnership to implement and scale a new patient monitoring platform across its 49 hospitals and 1,200 care sites.
  • In April 2024, OMRON Healthcare, Inc. (Japan) acquired Luscii healthtech B.V. (Netherlands), to enhance its integrated care solutions. This move aims to accelerate the adoption of remote patient monitoring and support OMRON's "Going for Zero" vision to reduce cardiovascular and cerebrovascular events.

Key Market Players

Want to explore hidden markets that can drive new revenue in Remote Patient Monitoring (RPM) Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Million/Billion (USD)
Segments covered Component, Indication, and End-user
Geographies covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

 

Key Questions Addressed by the Report

Which are the top industry players in the global Remote patient monitoring?
The top market players in the global Remote patient monitoring include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), VitalConnect (US), VivaLNK, Inc (US), Clear Arch, Inc (US), Optum, Inc (Vivifyhealth) (US), Blue Spark Technologies, Inc (US), Lightbeam (US), Cloud Diagnostics Canada ULC (Canada), Teladoc Health, Inc (US), and Guangdong Transtek Medical Electronics Co., Ltd (China).
Which component type has been included in the Remote patient monitoring report?
This report contains the following components:
  • Devices
    • By Function
      • Cardiac monitoring devices
      • Neurological monitoring devices
      • Respiratory monitoring devices
      • Blood glucose monitoring devices
      • Fetal & neonatal monitoring devices
      • Weight monitoring devices
      • Multiparameter monitoring devices
      • Pulse oximeter devices
      • Thermometers
      • Other monitoring devices (rehabilitation and physical therapy devices, fall detection devices, and others)
    • By Product type
      • Wearable devices
      • Implantable devices
      • Handheld & portable devices
      • Others (stationary devices, and others)
  • Software
    • By deployment model
      • On-premise model
      • Cloud-based model
    • By transmission type
      • Synchronous
      • Asynchronous
  • Services
Which region dominates the global Remote patient monitoring?
The global Remote patient monitoring is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds a substantial share, and the Asia Pacific is expected to register the highest growth rate during the forecast period.
Which end users have been included in the Remote patient monitoring report?
The report contains the following industry segments:
  • Healthcare Providers
    • Hospitals
    • Ambulatory surgical centers, ambulatory care centers, and other outpatient settings
    • Long-term care & assisted living facilities 
    • Home healthcare
    • Other healthcare providers (diagnostics & imagining centers, rehabilitation centers, behavioural health centers, and others)
  • Healthcare payers
  • Patients
  • Pharmaceutical & biotechnology companies
  • MedTech companies
  • Other end users (employer groups, government organizations, academic institutes, research centers, and others)
What is the total CAGR expected to be recorded for the Remote patient monitoring during 2024-2030?
The market is expected to record a CAGR of 12.7% from 2024–2030.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Remote Patient Monitoring (RPM) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
33
RESEARCH METHODOLOGY
40
EXECUTIVE SUMMARY
56
PREMIUM INSIGHTS
60
MARKET OVERVIEW
63
  • 5.1 INTRODUCTION
    DRIVERS
    - Transformation of patient care through digital innovation
    - Expansion of telehealth in remote patient monitoring
    - Rising prevalence of chronic diseases
    - Increasing geriatric population and rising uptake of RPM services
    - Growing need for cost-containment across healthcare facilities
    - Technological innovation in wearables, mhealth apps, and connected devices
    RESTRAINTS
    - High investments and lack of IT expertise
    - Behavioral barriers and healthcare affordability challenges in remote patient monitoring
    - Challenges associated with 2024 CMS regulations
    OPPORTUNITIES
    - Emergence of AI & ML
    - Gradual shift toward outpatient care environments
    - Increasing utilization for infectious disease diagnostics
    - Rising initiatives for hospital-at-home programs
    CHALLENGES
    - Concerns associated with data security
    - Data accessibility issues
    - incorporation of SDOH factors into RPM programs
  • 5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET
  • 5.3 INDUSTRY TRENDS
    GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Miniature wearable devices
    - Artificial intelligence & machine learning
    - Cloud computing
    - Patient engagement tools
    - EHR integration
    - Voice assistant integration
    COMPLEMENTARY TECHNOLOGIES
    - 5G connectivity
    - mHealth apps
    - Digital therapeutics
    - Telehealth platforms
    ADJACENT TECHNOLOGIES
    - POC diagnostics
    - Smart home health devices
  • 5.7 TARIFF & REGULATORY ANALYSIS
    TARIFF DATA (HS CODE 9018)
    TARIFF DATA (HS CODE 9021)
    TARIFF DATA (HS CODE 9022)
    REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
    REGULATORY ANALYSIS
  • 5.8 TRADE ANALYSIS
    TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 90189099)
    TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9021)
    TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9022)
  • 5.9 PRICING ANALYSIS
    INDICATIVE PRICING FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2023)
    INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES (2023)
  • 5.10 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF MANUFACTURERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.11 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING
    JURISDICTION AND TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
    LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 END-USER ANALYSIS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.14 KEY CONFERENCES AND EVENTS, 2025−2026
    REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025−2026
  • 5.15 CASE STUDY ANALYSIS
    REMOTE PATIENT MONITORING PORTAL AUTOMATION
    - Case 1: Cost savings and performance boost through automation
    PATIENT MONITORING PORTAL AUTOMATION
    - Case 2: RPM drives engagement and generates substantial returns
  • 5.16 INVESTMENT AND FUNDING SCENARIO
  • 5.17 REMOTE PATIENT MONITORING BUSINESS MODEL
    SUBSCRIPTION-BASED MODELS
    PLATFORM AS A SERVICE (PAAS)
    FREEMIUM MODELS WITH PREMIUM FEATURES
    COLLABORATIVE ECOSYSTEMS & PARTNERSHIPS
  • 5.18 IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET
    KEY USE CASES
    CASE STUDIES FOR GENERATIVE AI/AI IMPLEMENTATION
    - Case study 1: Enhancing remote patient monitoring for cancer treatment with NLP and HIPAA-compliant annotation
    - Case study 2: Leveraging AI for proactive infection prevention in hospitals
    IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
    - Telehealth & telemedicine
    - Wearable devices
    - Digital healthcare
    - Home healthcare
    USER READINESS & IMPACT ASSESSMENT
    - User readiness
    - Impact assessment
  • 5.19 REIMBURSEMENT SCENARIO
REMOTE PATIENT MONITORING MARKET, BY COMPONENT
126
  • 6.1 INTRODUCTION
  • 6.2 DEVICES
    BY FUNCTION
    - Cardiac monitoring devices
    - Neurological monitoring devices
    - Respiratory monitoring devices
    - Blood glucose monitoring devices
    - Fetal & neonatal monitoring devices
    - Weight monitoring devices
    - Multiparameter monitoring devices
    - Pulse oximeter devices
    - Thermometers
    - Other monitoring devices
    BY TYPE
    - Wearable devices
    - Implantable devices
    - Handheld & portable devices
    - Other devices
  • 6.3 SOFTWARE
    SOFTWARE, BY DEPLOYMENT MODEL
    - On-premise models
    - Cloud-based models
    SOFTWARE, BY TRANSMISSION TYPE
    - Synchronous transmission
    - Asynchronous transmission
  • 6.4 SERVICES
    EXPANSION OF TELEMEDICINE PLATFORMS AND INTEGRATION OF SERVICE MODELS TO SUPPORT MARKET GROWTH
REMOTE PATIENT MONITORING MARKET, BY INDICATION
150
  • 7.1 INTRODUCTION
  • 7.2 ONCOLOGY
    GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET
  • 7.3 CARDIOLOGY
    HIGH INCIDENCE OF CVD TO PROPEL MARKET
  • 7.4 NEUROLOGY
    INCREASING PREVALENCE OF NEUROLOGICAL CONDITIONS TO FUEL MARKET
  • 7.5 DIABETES
    GROWING FOCUS ON TELEHEALTH CONSULTATIONS FOR DIABETES MANAGEMENT TO BOOST DEMAND
  • 7.6 SLEEP DISORDERS
    INCREASING INCIDENCE OF SLEEP APNEA TO SUPPORT MARKET GROWTH
  • 7.7 RESPIRATORY DISEASES
    RISING CASES OF COPD AND ASTHMA TO FUEL MARKET
  • 7.8 WELLNESS IMPROVEMENT
    UTILIZATION OF WEIGHT MANAGEMENT & PERSONAL HEALTH APPS TO SUPPORT MARKET GROWTH
  • 7.9 MENTAL HEALTH
    GROWING FOCUS ON DEVELOPMENT OF PREDICTIVE HEALTH MODELS FOR COGNITIVE THERAPY TO PROPEL MARKET
  • 7.10 OTHER INDICATIONS
REMOTE PATIENT MONITORING MARKET, BY END USER
162
  • 8.1 INTRODUCTION
  • 8.2 HEALTHCARE PROVIDERS
    HOSPITALS
    - Ability to purchase technologically advanced telehealth devices to fuel market
    ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
    - Increasing demand for cost-effective perioperative devices to fuel market
    LONG-TERM CARE & ASSISTED LIVING FACILITIES
    - Expanding geriatric population and growing focus on chronic disease management to fuel market
    HOME HEALTHCARE
    - Growing preference for remote care to drive market
    OTHER HEALTHCARE PROVIDERS
  • 8.3 HEALTHCARE PAYERS
    LOW COSTS AND IMPROVED HEALTHCARE FACILITIES TO DRIVE MARKET
  • 8.4 PATIENTS
    INCREASING FOCUS ON AI INTEGRATION INTO WEARABLE DEVICES TO BOOST DEMAND
  • 8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    RISING NEED FOR ENHANCED CLINICAL TRIAL OUTCOMES TO SUPPORT MARKET GROWTH
  • 8.6 MEDTECH COMPANIES
    INTEGRATION OF RPM WITH MEDTECH SOLUTIONS FOR DIAGNOSTIC ACCURACY TO FUEL MARKET
  • 8.7 OTHER END USERS
REMOTE PATIENT MONITORING MARKET, BY REGION
174
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Supportive regulatory frameworks for AI implementation in wearable devices to boost demand
    CANADA
    - Growing need to curtail healthcare costs to drive market
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Favorable reimbursements for technological innovation to propel market
    UK
    - Government support for AI implementation to boost demand
    FRANCE
    - Implementation of ETAPES program to fuel market
    ITALY
    - Growing focus on digital transformation for value-centric patient care to drive market
    SPAIN
    - Rising funding investments for digital health plans to boost market
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Shortage of physicians and growing focus on RPM solutions to support market growth
    JAPAN
    - Rising geriatric population and subsequent rise in preventive care to drive market
    INDIA
    - Expanding target patient population to drive market
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Growing focus on telehealth consultations to drive market
    MEXICO
    - Improvements in healthcare infrastructure to boost demand
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
  • 9.7 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Government initiatives for investments in RPM solutions to support market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
269
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET
  • 10.3 REVENUE ANALYSIS, 2019–2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Component footprint
    - Indication footprint
    - End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of startups/SMEs
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/SOFTWARE COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT/SERVICE LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
297
  • 11.1 KEY PLAYERS
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION)
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    GE HEALTHCARE
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    ORACLE
    - Business overview
    - Products/Services offered
    - Recent developments
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products/Services offered
    - Recent developments
    NIHON KOHDEN CORPORATION
    - Business overview
    - Products/Services offered
    - Recent developments
    SIEMENS HEALTHINEERS AG
    - Business overview
    - Products/Services offered
    - Recent developments
    BAXTER
    - Business overview
    - Products/Services offered
    - Recent developments
    BIOBEAT
    - Business overview
    - Products/Services offered
    - Recent developments
    BIOTRONIK
    - Business overview
    - Products/Services offered
    - Recent developments
    VITALCONNECT
    - Business overview
    - Products/Services offered
    - Recent developments
    VIVALNK, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    CLEARARCH, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    OPTUM, INC. (VIVIFY HEALTH, PART OF OPTUM)
    - Business overview
    - Products/Services offered
    BLUE SPARK TECHNOLOGIES, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    LIGHTBEAM
    - Business overview
    - Products/Services offered
    - Recent developments
    CLOUD DIAGNOSTICS CANADA ULC
    - Business overview
    - Products/Services offered
    - Recent developments
    TELADOC HEALTH, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.
    - Business overview
    - Products/Services offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    CARESIMPLE INC.
    TIMEDOC, INC.
    MD REVOLUTION INC.
    OPTIMIZE HEALTH, INC.
    HEALTH RECOVERY SOLUTIONS
APPENDIX
386
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 FACTOR ANALYSIS
  • TABLE 3 RISK ASSESSMENT: REMOTE PATIENT MONITORING MARKET
  • TABLE 4 REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS
  • TABLE 5 RECENT DEVELOPMENTS OF AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2022–DECEMBER 2024
  • TABLE 6 TOP 5 HEALTHCARE ORGANIZATIONS IMPACTED BY SECURITY BREACHES
  • TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 NORTH AMERICA: REGULATORY ANALYSIS
  • TABLE 13 EUROPE: REGULATORY ANALYSIS
  • TABLE 14 ASIA PACIFIC: REGULATORY ANALYSIS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY ANALYSIS
  • TABLE 16 LATIN AMERICA: REGULATORY ANALYSIS
  • TABLE 17 INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2023)
  • TABLE 18 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY DEVICE (2023)
  • TABLE 19 INDICATIVE PRICE OF REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023 (USD)
  • TABLE 20 REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 21 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
  • TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY END USERS
  • TABLE 23 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING
  • TABLE 24 UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET
  • TABLE 25 END-USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET
  • TABLE 26 CPT CODES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET
  • TABLE 27 REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 28 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 29 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 30 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 31 NEUROLOGICAL MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 32 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 33 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 34 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 35 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 36 MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 37 PULSE OXIMETER DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 38 THERMOMETERS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 39 OTHER MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 40 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 41 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (THOUSAND UNITS)
  • TABLE 42 WEARABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 43 IMPLANTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 44 HANDHELD & PORTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 45 OTHER DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 46 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 47 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 48 ON-PREMISE MODELS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 49 CLOUD-BASED MODELS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 50 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 51 SYNCHRONOUS TRANSMISSION MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 52 ASYNCHRONOUS TRANSMISSION MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 53 REMOTE PATIENT MONITORING MARKET FOR SERVICES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 54 REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 55 REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 56 REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 57 REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 58 REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 59 REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 60 REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 61 REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 62 REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 63 REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 64 REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 65 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 66 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 67 REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 68 REMOTE PATIENT MONITORING MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 69 REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 70 REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 71 REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 72 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 73 REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 74 REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 75 REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 76 REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 77 REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 80 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 84 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 85 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 87 US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 88 US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 89 US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 90 US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 91 US: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 92 US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 93 US: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 94 CANADA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 95 CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 96 CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 97 CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 98 CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 99 CANADA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 100 CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 101 CANADA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 102 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 103 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 104 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 105 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 106 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 107 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 108 EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 109 EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 110 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 111 GERMANY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 112 GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 113 GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 114 GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 115 GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 116 GERMANY: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 117 GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 118 GERMANY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 119 UK: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 120 UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 121 UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 122 UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 123 UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 124 UK: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 125 UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 126 UK: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 127 FRANCE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 128 FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 129 FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 130 FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 131 FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 132 FRANCE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 133 FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 134 FRANCE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 135 ITALY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 136 ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 137 ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 138 ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 139 ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 140 ITALY: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 141 ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 142 ITALY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 143 SPAIN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 144 SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 145 SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 146 SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 147 SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 148 SPAIN: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 149 SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 150 SPAIN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 151 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 152 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 153 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 154 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 155 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 156 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 157 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 158 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 168 CHINA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 169 CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 170 CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 171 CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 172 CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 173 CHINA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 174 CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 175 CHINA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 176 JAPAN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 177 JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 178 JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 179 JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 180 JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 181 JAPAN: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 182 JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 183 JAPAN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 184 INDIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 185 INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 186 INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 187 INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 188 INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 189 INDIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 190 INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 191 INDIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 192 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 193 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 200 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 201 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 202 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 203 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 204 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 206 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 207 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 208 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 209 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 210 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 211 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 212 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 213 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 214 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 215 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 216 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 217 MEXICO: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 218 MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 219 MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 220 MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 221 MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 222 MEXICO: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 223 MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 224 MEXICO: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 225 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 226 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 227 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 228 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 229 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 230 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 231 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 232 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 234 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 236 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 237 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 238 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 239 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 240 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 241 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 244 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 245 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 247 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 248 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 249 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 250 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 251 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 252 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 253 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)
  • TABLE 254 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 255 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 256 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 257 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 258 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021–JANUARY 2025
  • TABLE 259 REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION
  • TABLE 260 REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT
  • TABLE 261 REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT
  • TABLE 262 REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT
  • TABLE 263 REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT
  • TABLE 264 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 265 REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
  • TABLE 266 REMOTE PATIENT MONITORING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 267 REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 268 REMOTE PATIENT MONITORING MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 269 REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 270 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 271 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED
  • TABLE 272 KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
  • TABLE 273 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 274 OMRON CORPORATION: COMPANY OVERVIEW
  • TABLE 275 OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 276 OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
  • TABLE 277 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 278 OMRON HEALTHCARE, INC.: OTHER DEVELOPMENTS, JANUARY 2021−JANUARY 2025
  • TABLE 279 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 280 MEDTRONIC: PRODUCTS/SERVICES OFFERED
  • TABLE 281 MEDTRONIC: PRODUCT/SERVICE APPROVALS, JANUARY 2021−JANUARY 2025
  • TABLE 282 MEDTRONIC: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 283 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 284 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED
  • TABLE 285 GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
  • TABLE 286 GE HEALTHCARE: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 287 ABBOTT: COMPANY OVERVIEW
  • TABLE 288 ABBOTT: PRODUCTS/SERVICES OFFERED
  • TABLE 289 ABBOTT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
  • TABLE 290 ABBOTT: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 291 ABBOTT: EXPANSIONS, JANUARY 2021−JANUARY 2025
  • TABLE 292 ORACLE: COMPANY OVERVIEW
  • TABLE 293 ORACLE: PRODUCTS/SERVICES OFFERED
  • TABLE 294 ORACLE: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 295 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 296 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 297 BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021−JANUARY 2025
  • TABLE 298 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 299 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021−JANUARY 2025
  • TABLE 300 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 301 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 302 NIHON KOHDEN CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
  • TABLE 303 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 304 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2021−JANUARY 2025
  • TABLE 305 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 306 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED
  • TABLE 307 SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
  • TABLE 308 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 309 BAXTER: COMPANY OVERVIEW
  • TABLE 310 BAXTER: PRODUCTS/SERVICES OFFERED
  • TABLE 311 BAXTER: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
  • TABLE 312 BAXTER: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 313 BIOBEAT: COMPANY OVERVIEW
  • TABLE 314 BIOBEAT: PRODUCTS/SERVICES OFFERED
  • TABLE 315 BIOBEAT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
  • TABLE 316 BIOBEAT: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 317 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 318 BIOTRONIK: PRODUCTS/SERVICES OFFERED
  • TABLE 319 BIOTRONIK: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025
  • TABLE 320 BIOTRONIK: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 321 VITALCONNECT: COMPANY OVERVIEW
  • TABLE 322 VITALCONNECT: PRODUCTS/SERVICES OFFERED
  • TABLE 323 VITALCONNECT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
  • TABLE 324 VITALCONNECT: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 325 VITALCONNECT: OTHER DEVELOPMENTS, JANUARY 2021−JANUARY 2025
  • TABLE 326 VIVALNK, INC.: COMPANY OVERVIEW
  • TABLE 327 VIVALNK, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 328 VIVALNK, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021−JANUARY 2025
  • TABLE 329 VIVALNK, INC.: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 330 CLEARARCH, INC.: COMPANY OVERVIEW
  • TABLE 331 CLEARARCH, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 332 CLEARARCH, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
  • TABLE 333 CLEARARCH, INC.: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 334 OPTUM, INC.: COMPANY OVERVIEW
  • TABLE 335 OPTUM, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 336 BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 337 BLUE SPARK TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 338 BLUE SPARK TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
  • TABLE 339 BLUE SPARK TECHNOLOGIES, INC.: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 340 BLUE SPARK TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021−JANUARY 2025
  • TABLE 341 LIGHTBEAM: COMPANY OVERVIEW
  • TABLE 342 LIGHTBEAM: PRODUCTS/SERVICES OFFERED
  • TABLE 343 LIGHTBEAM: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 344 CLOUD DIAGNOSTICS CANADA ULC: COMPANY OVERVIEW
  • TABLE 345 CLOUD DIAGNOSTICS CANADA ULC: PRODUCTS/SERVICES OFFERED
  • TABLE 346 CLOUD DIAGNOSTICS CANADA ULC: PRODUCT LAUNCHES, JANUARY 2021−JANUARY 2025
  • TABLE 347 CLOUD DIAGNOSTICS CANADA ULC: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 348 TELADOC HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 349 TELADOC HEALTH, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 350 TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
  • TABLE 351 TELADOC HEALTH, INC.: DEALS, JANUARY 2021−JANUARY 2025
  • TABLE 352 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 353 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 354 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025
LIST OF FIGURES
 
  • FIGURE 1 REMOTE PATIENT MONITORING MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION
  • FIGURE 8 REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH
  • FIGURE 9 BOTTOM-UP APPROACH: END-USER SPENDING ON REMOTE PATIENT MONITORING
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 REMOTE PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 18 TRANSFORMATION OF PATIENT CARE THROUGH DIGITIZATION TO PROPEL MARKET
  • FIGURE 19 HEALTHCARE PROVIDERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
  • FIGURE 20 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 21 EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD
  • FIGURE 22 REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 DIGITAL HEALTH FUNDING HISTORY, 2020−2024 (USD BILLION)
  • FIGURE 24 NUMBER OF DEALS IN DIGITAL HEALTH (2020−2024)
  • FIGURE 25 US: MEDICARE-CERTIFIED ASCS, BY STATE (AS OF SEPTEMBER 2024)
  • FIGURE 26 HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009–2024
  • FIGURE 27 HEALTHCARE SECURITY BREACHES, 2009–2023
  • FIGURE 28 REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 IMPORT OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 31 EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 32 IMPORT OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 33 EXPORTS OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 34 IMPORT OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 36 REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 37 GLOBAL PATENT PUBLICATION TRENDS IN REMOTE PATIENT MONITORING MARKET, 2015–2024
  • FIGURE 38 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS (JANUARY 2015–NOVEMBER 2024)
  • FIGURE 39 LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015–NOVEMBER 2024)
  • FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING
  • FIGURE 41 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY COMPONENT
  • FIGURE 42 POTENTIAL OF GENERATIVE AI/AI IN REMOTE PATIENT MONITORING ACROSS INDUSTRIES
  • FIGURE 43 NEW CANCER CASES IN US, 2024
  • FIGURE 44 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 45 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 46 REVENUE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, 2019–2023 (USD MILLION)
  • FIGURE 47 MARKET SHARE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET (2023)
  • FIGURE 48 REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 49 REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT
  • FIGURE 50 REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 51 EV/EBITDA OF KEY VENDORS
  • FIGURE 52 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 53 REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 54 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 OMRON CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 56 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 57 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 58 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 59 ORACLE: COMPANY SNAPSHOT (2023)
  • FIGURE 60 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 61 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 63 BAXTER: COMPANY SNAPSHOT (2023)
  • FIGURE 64 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2023)

 

The study involved major activities in estimating the current market size for the remote patient monitoring market. Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews

The following is a breakdown of the primary respondents:

Remote Patient Monitoring (RPM) Market

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Tiers of companies are defined on the basis of their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

The research methodology used to estimate the market size includes the following:

Remote Patient Monitoring (RPM) Market

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

Market Definition

The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.

Stakeholders

  • RPM Equipment and devices Manufacturers
  • Suppliers and Distributors of RPM Equipment
  • RPM software provider
  • Healthcare IT Service Providers
  • Healthcare Insurance Companies/Payers
  • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
  • Venture Capitalists
  • Government Bodies/Regulatory Bodies
  • Corporate Entities
  • Accountable Care Organizations
  • RPM Resource Centers
  • Research and Consulting Firms
  • Medical Research Institutes
  • Clinical Departments

Report Objectives

  • To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches and enhancements and investments, partnerships, collaborations, acquisitions, expansions, funding, grant, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.

 

Previous Versions of this Report

Remote Patient Monitoring Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End User (Providers, Hospitals, Clinics, Homecare, Patients, Payers) & Region - Global Forecast to 2027

Report Code HIT 7776
Published in Nov, 2023, By MarketsandMarkets™

Remote Patient Monitoring (RPM) Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End user (Providers, Hospitals, Clinics, Homecare, Patients, Payers) - Global Forecast to 2027

Report Code HIT 7776
Published in Mar, 2022, By MarketsandMarkets™

Remote Patient Monitoring (RPM) Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End user (Providers, Hospitals, Clinics, Homecare, Patients, Payers) - Global Forecast to 2027

Report Code HIT 7776
Published in Nov, 2020, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Remote Patient Monitoring (RPM) Market

Chad

Nov, 2021

Can you explain your reasoning around the projection of the $72.8 Billion Mkt for RPM in North America? Thanks.

Amber

Mar, 2022

Which are growth driving factors for the global growth of Remote Patient Monitoring Market?.

Willie

Mar, 2022

What will be the size of the Remote Patient Monitoring Market for the European region?.

DMCA.com Protection Status